SEC Info - Commonwealth Income & Growth Fund V - ‘10-Q’ for 6/30/22

SEC Info℠

Home

Help

Please Sign In

Commonwealth Income & Growth Fund V – ‘10-Q’ for 6/30/22 – ‘EX-101.DEF’

On: Tuesday, 8/23/22, at 10:13am ET · For: 6/30/22 · Accession #: 1654954-22-11685 · File #: 333-108057

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/23/22  Commonwealth Income & Growth Fd V 10-Q        6/30/22   46:1.7M                                   Blueprint/FA

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    373K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     15K 
11: R1          Cover                                               HTML     64K 
12: R2          Condensed Balance Sheets                            HTML     85K 
13: R3          Condensed Balance Sheets (Parenthetical)            HTML     20K 
14: R4          Condensed Statements of Operations (Unaudited)      HTML     72K 
15: R5          Condensed Statement of Partners' Equity             HTML     43K 
                (Unaudited)                                                      
16: R6          Condensed Statements of Cash Flow (Unaudited)       HTML     30K 
17: R7          Business                                            HTML     22K 
18: R8          Summary of Significant Accounting Policies          HTML     28K 
19: R9          Information Technology, Medical Technology,         HTML     26K 
                Telecommunications Technology, Inventory                         
                Management and Other Business-Essential Capital                  
                Equipment ("Equipment")                                          
20: R10         Related Party Transactions                          HTML     33K 
21: R11         Notes Payable                                       HTML     29K 
22: R12         Supplemental Cash Flow Information                  HTML     20K 
23: R13         Commitments and Contingencies                       HTML     27K 
24: R14         Summary of Significant Accounting Policies          HTML     33K 
                (Policies)                                                       
25: R15         Summary of Significant Accounting Policies          HTML     19K 
                (Tables)                                                         
26: R16         Information Technology, Medical Technology,         HTML     21K 
                Telecommunications Technology, Inventory                         
                Management and Other Business-Essential Capital                  
                Equipment ("Equipment") (Tables)                                 
27: R17         Related Party Transactions (Tables)                 HTML     31K 
28: R18         Notes Payable (Tables)                              HTML     26K 
29: R19         Supplemental Cash Flow Information (Tables)         HTML     19K 
30: R20         Business (Details Narrative)                        HTML     19K 
31: R21         Summary of Significant Accounting Policies          HTML     20K 
                (Details)                                                        
32: R22         Summary of Significant Accounting Policies          HTML     18K 
                (Details Narrative)                                              
33: R23         Information Technology Medical Technology           HTML     27K 
                Telecommunications Technology Inventory Management               
                Equipment and other BusinessEssential Capital                    
                Equipment (Equipment) (Details)                                  
34: R24         Information Technology Medical Technology           HTML     24K 
                Telecommunications Technology Inventory Management               
                Equipment and other BusinessEssential Capital                    
                Equipment (Equipment) (Details Narrative)                        
35: R25         Related Party Transactions (Details)                HTML     21K 
36: R26         Related Party Transactions (Details Narrative)      HTML     26K 
37: R27         Notes Payable (Details)                             HTML     22K 
38: R28         Notes Payable (Details 1)                           HTML     26K 
39: R29         Notes Payable (Details Narrative)                   HTML     16K 
40: R30         Supplemental Cash Flow Information (Details)        HTML     17K 
41: R31         Commitments and Contingencies (Details Narrative)   HTML     37K 
44: XML         IDEA XML File -- Filing Summary                      XML     77K 
42: XML         XBRL Instance -- cigf5_10q_htm                       XML    291K 
43: EXCEL       IDEA Workbook of Financial Reports                  XLSX     60K 
 8: EX-101.CAL  XBRL Calculations -- cigf5-20220630_cal              XML     76K 
10: EX-101.DEF  XBRL Definitions -- cigf5-20220630_def               XML     94K 
 7: EX-101.LAB  XBRL Labels -- cigf5-20220630_lab                    XML    323K 
 9: EX-101.PRE  XBRL Presentations -- cigf5-20220630_pre             XML    241K 
 6: EX-101.SCH  XBRL Schema -- cigf5-20220630                        XSD     84K 
45: JSON        XBRL Instance as JSON Data -- MetaLinks              151±   204K 
46: ZIP         XBRL Zipped Folder -- 0001654954-22-011685-xbrl      Zip     93K

‘EX-101.DEF’ — XBRL Definitions — cigf5-20220630_def

This Exhibit is an XBRL XML File.

<?xml version="1.0" standalone="yes" encoding="windows-1252"?>

<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">

<link:roleRef roleURI="http://cigf5.com/role/Cover" xlink:href="cigf5-20220630.xsd#Cover" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/CondensedBalanceSheets" xlink:href="cigf5-20220630.xsd#CondensedBalanceSheets" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/CondensedBalanceSheetsParenthetical" xlink:href="cigf5-20220630.xsd#CondensedBalanceSheetsParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/CondensedStatementsOfOperationsUnaudited" xlink:href="cigf5-20220630.xsd#CondensedStatementsOfOperationsUnaudited" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/CondensedStatementOfPartnersEquityUnaudited" xlink:href="cigf5-20220630.xsd#CondensedStatementOfPartnersEquityUnaudited" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/CondensedStatementsOfCashFlowUnaudited" xlink:href="cigf5-20220630.xsd#CondensedStatementsOfCashFlowUnaudited" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/Business" xlink:href="cigf5-20220630.xsd#Business" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipment" xlink:href="cigf5-20220630.xsd#InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipment" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/RelatedPartyTransactions" xlink:href="cigf5-20220630.xsd#RelatedPartyTransactions" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/NotesPayable" xlink:href="cigf5-20220630.xsd#NotesPayable" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/SupplementalCashFlowInformation" xlink:href="cigf5-20220630.xsd#SupplementalCashFlowInformation" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/CommitmentsAndContingencies" xlink:href="cigf5-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipmentTables" xlink:href="cigf5-20220630.xsd#InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipmentTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/RelatedPartyTransactionsTables" xlink:href="cigf5-20220630.xsd#RelatedPartyTransactionsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/NotesPayableTables" xlink:href="cigf5-20220630.xsd#NotesPayableTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/SupplementalCashFlowInformationTables" xlink:href="cigf5-20220630.xsd#SupplementalCashFlowInformationTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/BusinessDetailsNarrative" xlink:href="cigf5-20220630.xsd#BusinessDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetails" xlink:href="cigf5-20220630.xsd#InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetailsNarrative" xlink:href="cigf5-20220630.xsd#InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/RelatedPartyTransactionsDetails" xlink:href="cigf5-20220630.xsd#RelatedPartyTransactionsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="cigf5-20220630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/NotesPayableDetails" xlink:href="cigf5-20220630.xsd#NotesPayableDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/NotesPayableDetails1" xlink:href="cigf5-20220630.xsd#NotesPayableDetails1" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/NotesPayableDetailsNarrative" xlink:href="cigf5-20220630.xsd#NotesPayableDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/SupplementalCashFlowInformationDetails" xlink:href="cigf5-20220630.xsd#SupplementalCashFlowInformationDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cigf5.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cigf5-20220630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll"/>

<link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">

<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCover"/>

</link:definitionLink>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedBalanceSheets" xlink:title="000002 - Statement - Condensed Balance Sheets"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedBalanceSheetsParenthetical" xlink:title="000003 - Statement - Condensed Balance Sheets (Parenthetical)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedStatementsOfOperationsUnaudited" xlink:title="000004 - Statement - Condensed Statements of Operations (unaudited)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedStatementOfPartnersEquityUnaudited" xlink:title="000005 - Statement - Condensed Statement of Partners' Equity (unaudited)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="30"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" order="40" xbrldt:contextElement="segment"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_GeneralPartnersMember" xlink:label="loc_cigf5GeneralPartnersMember"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cigf5GeneralPartnersMember" order="21"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_LimitedPartnersMember" xlink:label="loc_cigf5LimitedPartnersMember"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" order="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" order="2"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" order="3"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_Redemption" xlink:label="loc_cigf5Redemption"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cigf5Redemption" order="4"/>

</link:definitionLink>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedStatementsOfCashFlowUnaudited" xlink:title="000006 - Statement - Condensed Statements of Cash Flow (unaudited)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/Business" xlink:title="000007 - Disclosure - Business"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="000008 - Disclosure - Summary of Significant Accounting Policies"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipment" xlink:title="000009 - Disclosure - Information Technology, Medical Technology, Telecommunications Technology, Inventory Management and Other Business-Essential Capital Equipment ("Equipment")"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/RelatedPartyTransactions" xlink:title="000010 - Disclosure - Related Party Transactions"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayable" xlink:title="000011 - Disclosure - Notes Payable"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/SupplementalCashFlowInformation" xlink:title="000012 - Disclosure - Supplemental Cash Flow Information"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/CommitmentsAndContingencies" xlink:title="000013 - Disclosure - Commitments and Contingencies"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="000014 - Disclosure - Summary of Significant Accounting Policies (Policies)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="000015 - Disclosure - Summary of Significant Accounting Policies (Tables)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipmentTables" xlink:title="000016 - Disclosure - Information Technology, Medical Technology, Telecommunications Technology, Inventory Management and Other Business-Essential Capital Equipment ("Equipment") (Tables)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/RelatedPartyTransactionsTables" xlink:title="000017 - Disclosure - Related Party Transactions (Tables)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayableTables" xlink:title="000018 - Disclosure - Notes Payable (Tables)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/SupplementalCashFlowInformationTables" xlink:title="000019 - Disclosure - Supplemental Cash Flow Information (Tables)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/BusinessDetailsNarrative" xlink:title="000020 - Disclosure - Business (Details Narrative)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="000021 - Disclosure - Summary of Significant Accounting Policies (Details)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="30"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" order="40" xbrldt:contextElement="segment"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" order="21"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndDueFromBanks" xlink:label="loc_us-gaapCashAndDueFromBanks"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount"/>

</link:definitionLink>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetails" xlink:title="000023 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment and other BusinessEssential Capital Equipment (Equipment) (Details)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetailsNarrative" xlink:title="000024 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment and other BusinessEssential Capital Equipment (Equipment) (Details Narrative)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/RelatedPartyTransactionsDetails" xlink:title="000025 - Disclosure - Related Party Transactions (Details)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000026 - Disclosure - Related Party Transactions (Details Narrative)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayableDetails" xlink:title="000027 - Disclosure - Notes Payable (Details)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="30"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" order="40" xbrldt:contextElement="segment"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_NoteOneMember" xlink:label="loc_cigf5NoteOneMember"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_cigf5NoteOneMember" order="21"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" order="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription"/>

</link:definitionLink>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayableDetails1" xlink:title="000028 - Disclosure - Notes Payable (Details 1)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayableDetailsNarrative" xlink:title="000029 - Disclosure - Notes Payable (Details Narrative)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/SupplementalCashFlowInformationDetails" xlink:title="000030 - Disclosure - Supplemental Cash Flow Information (Details)"/>

<link:definitionLink xlink:type="extended" xlink:role="http://cigf5.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="000031 - Disclosure - Commitments and Contingencies (Details Narrative)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="30"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="40" xbrldt:contextElement="segment"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="40"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="60"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" order="70" xbrldt:contextElement="segment"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_FinraMember" xlink:label="loc_cigf5FinraMember"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_cigf5FinraMember" order="51"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" order="52"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" order="53"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_MsSpringsteenAbbottMember" xlink:label="loc_cigf5MsSpringsteenAbbottMember"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_cigf5MsSpringsteenAbbottMember" order="54"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityCosts" xlink:label="loc_us-gaapFacilityCosts"/>

<link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFacilityCosts" order="1"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_NumberOfItemsList" xlink:label="loc_cigf5NumberOfItemsList"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_AmountForNumberOfItemsList" xlink:label="loc_cigf5AmountForNumberOfItemsList"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_NumberOfRemainingListItems" xlink:label="loc_cigf5NumberOfRemainingListItems"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_AmountForRemainingListItems" xlink:label="loc_cigf5AmountForRemainingListItems"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings" xlink:label="loc_us-gaapIncreaseDecreaseInBillingInExcessOfCostOfEarnings"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_ReductionInProposedFine" xlink:label="loc_cigf5ReductionInProposedFine"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>

<link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_ReallocatedFunds" xlink:label="loc_cigf5ReallocatedFunds"/>

</link:definitionLink>

</link:linkbase>

↑Top

Filing Submission 0001654954-22-011685 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Commonwealth Income & Growth Fund V – ‘10-Q’ for 6/30/22 – ‘EX-101.DEF’

On: Tuesday, 8/23/22, at 10:13am ET · For: 6/30/22 · Accession #: 1654954-22-11685 · File #: 333-108057

Previous ‘10-Q’: ‘10-Q’ on 5/18/22 for 3/31/22 · Next: ‘10-Q’ on 11/29/22 for 9/30/22 · Latest: ‘10-Q’ on 11/14/23 for 9/30/23

Quarterly Report — Form 10-QFiling Table of Contents

‘EX-101.DEF’ — XBRL Definitions — cigf5-20220630_def

This Exhibit is an XBRL XML File.

Quarterly Report — Form 10-Q

Filing Table of Contents